Log In
Company Data

ImmunityBio Inc.

Advanced Market Data
Ticker
IBRX
Current Price
$9.15 2.01%
Market Cap
$6.2B
Price Target
Refer to Report
Volume
14.6M
52wk Range
$1.25 - $10.53
Advanced Market Data

Overview

ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company’s immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T cell) immune systems to create long-term immunological memory.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In